Conditions
Gonorrhea
3 articles published between November 25, 2025 and July 9, 2026.
Covered in Science and Global Health.
WHAT THE STUDY ACTUALLY SAYSYears of observational data suggested 4CMenB cut gonorrhea risk by a third or more. A placebo-controlled trial in 654 people at high risk found essentially no effect at all.
4 min read
THE DRUG DOCKETZoliflodacin is the first antibiotic developed solely for gonorrhoea in decades, and a non-profit holds the rights to register it across most of the world.
4 min read
New EGASP surveillance data released for World AMR Awareness Week show cefixime resistance up from 1.7% to 11% and ciprofloxacin resistance at 95% across 12 reporting countries.
4 min read
This page indexes this newspaper’s reporting on Gonorrhea. It is not a medical reference entry, and nothing here is medical advice. See our editorial standards.